corneal opacities

EDICT Syndrome

Clinical Characteristics
Ocular Features: 

This is a rare disorder with multiple anterior segment anomalies.  The corneal stroma is thinned in the range of 330 to 460 um with uniform steepening (no cone).  The epithelium may be irregular and edematous, the stroma is diffusely hazy, and the endothelium is irregular with many guttae.  Anterior polar cataracts are likely congenital and often require removal before the age of 20 years.  The pupils are often eccentric and difficult to dilate.  The iris stroma may appear atrophic.  Visual acuity, even in the aphakic condition, is in the range of 20/30 to 20/160.

Histological studies show attenuation of the endothelium with cellular overlapping and aggregates of fibrillar material that stains for cytokeratin.  Descemet membrane is thickened as is the epithelial basement membrane and both intracellular and extracellular lipid deposition is seen throughout the stroma and the Bowman membrane.

Systemic Features: 

No systemic abnormalities have been reported.

Genetics

This is an autosomal dominant disorder resulting from a heterozygous single base substitution (57C-T) in the MIR184 gene (15q25.1).

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Cataract removal and penetrating keratoplasty can be helpful.  It is unknown whether the donor corneal tissue develops similar opacities.

References
Article Title: 

Corneal Dystrophy, Congenital Stromal

Clinical Characteristics
Ocular Features: 

This rare congenital form of stromal dystrophy is sometimes considered a disorder of collagen fibrils with abnormally small diameters.  These may appear disorganized in areas.  Corneal opacities are often evident at birth or during the neonatal period.  Numerous small spots of fluffy, flaky deposits are found throughout the stroma creating a diffuse cloudy appearance and these may become more numerous with age indicating some progression.  The epithelium, Descemet membrane and the endothelium are not affected and the stroma is of normal or slightly increased thickness.  In some areas abnormal fibrillar layers are seen.  Although corneal erosions and photophobia are usually not clinically significant, acuity may be as low as hand motions and penetrating keratoplasty may be indicated.  In one series this was necessary at an average age of 20 years.  In the same series of 11 patients, 4 had strabismus, 3 eyes developed open angle glaucoma and band keratopathy was present in one patient.  Nystagmus has not been reported.

Deposition of abnormal decorin contributes to the stromal opacities. 

Systemic Features: 

No systemic abnormalities have been reported.

Genetics

This is a rare autosomal dominant stromal dystrophy that results from a mutation in the DCN gene on chromosome 12 (12q21.3).  Several frameshift mutations have been reported    in the decorin (DCN) gene causing premature truncation of the protein product.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Penetrating keratoplasty can be successful in restoring vision.  Grafts have been reported to remain clear for up to 36 years in more than half of the patients in one series but opacities recurred in others.

References
Article Title: 

Corneal Dystrophy, Schnyder

Clinical Characteristics
Ocular Features: 

Schnyder corneal dystrophy has its onset early in life as a haziness of the central cornea with some peripheral extension.  The stroma gradually becomes more hazy and eventually in about 50% of patients yellow-white crystalline deposits can be seen in an annular pattern in the Bowman layer and the adjacent stroma just beneath. The remaining layers of the cornea are not involved.  The needle-shaped crystals are often birefringent and composed of cholesterol and phospholipids. There is considerable variation in the progression of disease and in the symmetry of disease in the two eyes.  Visual acuity may be relatively good in young people but older patients with denser central opacification eventually require corneal transplantation for better vision.

Systemic Features: 

Some patients have hypercholesterolemia and hyperlipidemia.  Skin fibroblast cultures in one patient have shown cytoplasmic deposits consistent with unesterified cholesterol but another study failed to find such deposits in skin or conjunctiva.  Evidence points to a metabolic disorder of lipid metabolism in the cornea but the evidence for a more generalized systemic disorder is inconclusive.  Genu valgum has been reported in some patients.

Genetics

Schnyder crystalline dystrophy of the cornea results from a mutation in the UBIAD1 gene located on chromosome 1 (1p36.3).  Multiple mutations have been identified.  It is inherited in an autosomal dominant pattern.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Penetrating keratoplasty can be helpful in restoring vision but the corneal deposits and opacification often recur.  PTK procedures can also be beneficial.

References
Article Title: 

Schnyder corneal dystrophy

Weiss JS. Schnyder corneal dystrophy. Curr Opin Ophthalmol. 2009 Jul;20(4):292-8. Review.

PubMed ID: 
19398911

Genetic analysis of 14 families with Schnyder crystalline corneal dystrophy reveals clues to UBIAD1 protein function

Weiss JS, Kruth HS, Kuivaniemi H, Tromp G, Karkera J, Mahurkar S, Lisch W, Dupps WJ Jr, White PS, Winters RS, Kim C, Rapuano CJ, Sutphin J, Reidy J, Hu FR, Lu da W, Ebenezer N, Nickerson ML. Genetic analysis of 14 families with Schnyder crystalline corneal dystrophy reveals clues to UBIAD1 protein function. Am J Med Genet A. 2008 Feb 1;146(3):271-83. (Note: Erratum: Am. J. Med. Genet. 146A: 952-964, 2008.)

PubMed ID: 
18176953

Corneal Dystrophy, Fleck

Clinical Characteristics
Ocular Features: 

This stromal dystrophy may be congenital as it can be seen in the first years of life.  It is nonprogressive and generally has little clinical significance as it does not impair vision or require treatment in most cases.  It is usually diagnosed on routine examination from the presence of multiple, minute, whitish or grayish discrete opacities throughout the stroma.  The largest numbers are located centrally and posteriorly.  These may be flat, round or oval, and sometimes resemble snowflakes.  Keratocyte cell bodies contain cytoplasmic inclusions or vacuoles likely as the result of defective intracellular organelle trafficking.  Other layers such as the epithelium, Bowman layer, Descemet and endothelium are normal.  Expressivity is highly variable with considerable asymmetry of opacities in the two eyes and even unilateral involvement.

Systemic Features: 

No systemic abnormalities have been reported.

Genetics

This is an autosomal dominant stromal dystrophy resulting from mutations in the PIKFYVE (PIP5K3) gene on chromosome 2 (2q35).  A variety of missense, frameshift, and protein-truncating mutations have been found.  The gene product is a member of the phosphoinositide 3-kinase family that regulates the synthesis, sorting, and transportation of intracellular multivesicular bodies.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

No treatment is required in most cases.

References
Article Title: 

Corneal Dystrophy, Granular

Clinical Characteristics
Ocular Features: 

The corneal opacities in this disorder are usually located in the anterior stroma of the central cornea, and consist of discrete grayish-white, irregular granules with sharp margins.  The peripheral cornea and areas between the opacities remain clear.  The opacities may be apparent in the first decade but vision remains good throughout childhood.  The epithelial surface is usually smooth in children but adults can develop irregularities.  As the opacities enlarge and grow in number the cornea becomes increasingly opaque and older patients experience considerable loss of vision.  There is some variation in the number of opacities among individuals and considerable clinical heterogeneity occurs both within and between families.  The histologic appearance of the corneal deposits are said to be characteristic with eosinophilic deposits in the anterior stroma secondary to accumulations of mutant transforming growth factor beta induced protein.

The number and morphology of the granular deposits change throughout life, influenced to some extent by episodes of recurrent corneal erosions and age of patients.  Deposits become more annular and lattice-like in morphology, especially in the third decade and become more discoid by the fifth decade. 

It has been reported that the morphology and function of the meibomian glands are altered in this disease as well.

Systemic Features: 

No associated systemic disease has been described.

Genetics

This is another autosomal dominant corneal dystrophy resulting from mutations in the TGFBI gene (5q31) (others being Reis-Bucklers, Thiel-Behnke, lattice types I and IIIA, epithelial basement membrane disease, and Avellino). These are therefore allelic disorders of the same mutant gene.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Penetrating keratoplasty can be temporarily helpful in restoring vision but recurrence is common.  Opacities may also occur following the application of various types of refractive surgery (even in initially clear corneas).

References
Article Title: 

Corneal Dystrophy, Subepithelial Mucinous

Clinical Characteristics
Ocular Features: 

This disorder, reported so far in a single family, is an anterior corneal dystrophy with onset in the first decade of life.  The frequency of epithelial erosions tended to subside during adolescence but visual acuity continued to decline secondary to subepithelial nodular opacities and a generalized haze most dense centrally. No geographic lines are present and cystic changes in the epithelium were absent.  Bowman layer and deeper stuctures of the cornea are unaffected. Patients may have 20/30 vision into the fifth decade but after that it may decrease into the 20/400 range.  EM revealed accumulations of subepithelial fibrillar material.  Light microscopy and immunohistochemistry showed the material to be chondroitin-4-sulfate and dermatan sulfate.

Systemic Features: 

No systemic disease association has been reported.

Genetics

In the single 3 generation family reported, the pattern of inheritance was consistent with autosomal dominant inheritance.  No locus or mutation has been reported.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

The usual treatment for acute corneal erosions might be beneficial but other treatments have not been reported.  Penetrating keratoplasty and superficial keratectomy have been used on several patients but followup is not available.

References
Article Title: 

Corneal Dystrophy, Recurrent Epithelial Erosions

Clinical Characteristics
Ocular Features: 

Individuals have the onset of recurrent corneal erosions as a result of as yet unknown disease processes.  Onset is in the first decade of life (even in the first year of life)  often with some subepithelial haze or blebs while denser centrally located opacities develop with time.  Erosions often are precipitated by relatively minor trauma and are often difficult to treat, lasting for up to a week.  Fortunately, the erosions become less frequent as patients age and may cease altogether by the fifth decade of life.

Systemic Features: 

No systemic disease is associated with ERED.

Genetics

The few reported families have all had an autosomal dominant pattern of inheritance.  So far no locus or molecular defect has been identified.

The clinical features of this condition are found in other corneal dystrophies and it is likely that at least some of the reported cases may have had other unrecognized corneal conditions.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

The usual corneal erosion treatment of hypertonic solutions, bandage patching, and lubricating ointments may be helpful for acute erosions.  No long term preventative treatment has been found effective.  Corneal transplants remain clear centrally although peripheral opacities may reappear within a few years.

References
Article Title: 

Franceschetti Hereditary Recurrent Corneal Erosion

Lisch W, Bron AJ, Munier FL, Schorderet DF, Tiab L, Lange C, Saikia P, Reinhard T, Weiss JS, Gundlach E, Pleyer U, Lisch C, Auw-Haedrich C. Franceschetti Hereditary Recurrent Corneal Erosion. Am J Ophthalmol. 2012 Mar 7. [Epub ahead of print].

PubMed ID: 
22402249

Corneal Dystrophy, Gelatinous Drop-like

Clinical Characteristics
Ocular Features: 

White, gelatinous deposits of amyloid are seen in the subepithelial region giving the surface of the cornea a multilobulated appearance resembling a mulberry.  These usually appear in the first decade of life and cause photophobia as well as tearing from irritation caused by a severe foreign body sensation.  The corneal changes are variable and some patients have only a mild amount of anterior stromal opacification while others have subepithelial vascularization.  Vision loss can be severe when the deposits coalesce to opacify the cornea.  These deposits are found in the subepithelial region but in some families it may also be found in the Bowman layer.   The appearance of fusiform deposits in the stroma in some patients has led some to categorize gelatinous drop-like corneal dystrophy as a lattice dystrophy and have designated it as type III.  GDLD seems to occur more commonly in Japan but often has a much later onset and the lattice appearance is more striking suggesting that it may be a unique form of corneal amyloidosis.  True GDLD, however, occurs in diverse ethnic groups throughout the US, Europe, Latin America, and the Asian subcontinent.  Cataracts have been reported in several young individuals with corneal amyloidosis.

Systemic Features: 

No systemic abnormalities occur as part of this syndrome.

Genetics

Autosomal recessive corneal amyloidosis results from multiple mutations in the M1S1 (TACSTD2) gene located on chromosome 1 (1p32).

Pedigree: 
Autosomal recessive
Treatment
Treatment Options: 

No satisfactory permanent treatment has been found.  Ablative treatments may give temporary relief from symptoms and improve vision but the deposits recur within a few years.

References
Article Title: 

Corneal Dystrophy, Lisch Epithelial

Clinical Characteristics
Ocular Features: 

Of the anterior epithelial dystrophies, this one is unusual in the absence of spontaneous corneal erosions.  It is also the only one of this group to be an X-linked disorder.  Onset occurs in childhood and by adulthood vision can be significantly reduced.  Most individuals, however, retain vision in the range of 20/25 to 20/40 into the 7th and 8th decades.  Gray, feathery opacities in the anterior cornea often appear in a band-like or whorled pattern.  Vacuolization of the epithelial cells is responsible for this appearance but in Lisch dystrophy, these microcysts are empty compared to Reis-Bucklers, epithelial basement membrane, and Thiel-Behnke anterior dystrophies in which degenerative debris fills them.  In spite of the X-linked inheritance pattern, both males and carrier females may have similar corneal opacities since the mutation is dominant.

Systemic Features: 

No systemic disease is associated with Lisch epithelial dystrophy.

Genetics

Corneal opacities are seen in both sexes, and no father to son transmission has been reported.  This is a dominant X-linked disorder resulting from a mutation on the X chromosome (Xp22.3).  No responsible gene has been identified.

Pedigree: 
X-linked dominant, father affected
X-linked dominant, mother affected
Treatment
Treatment Options: 

The major clinical problem in this disorder is a reduction of vision in adults.  Epithelial debridement offers a temporary improvement in vision but the opacities recur within months. Soft contact lenses have been reported to reduce the epithelial opacities over several months of wear.  Discontinuation of wear can be followed by a return of the epithelial opacities.

References
Article Title: 

Corneal Dystrophy, Thiel-Behnke

Clinical Characteristics
Ocular Features: 

This type of anterior corneal dystrophy is genetically heterogeneous (caused by mutations in more than one locus). Recurrent corneal erosions are the main clinical feature and can begin in the first and second decades.  The epithelium is irregularly thickened while the Bowman layer and basal lamina of the basement membrane have degenerative changes which lead to the clinically evident honeycomb pattern of opacities.  Advanced changes in these tissues eventually leads to some vision loss.

The honeycomb pattern of degenerative changes in the corneal epithelium and Bowman membrane helps to distinguish this disorder from other anterior corneal dystrophies.  These are more prominent centrally with relative sparing of the juxtalimbal areas.  The epithelial basement membrane may be missing in some areas.  Histology is required for a definitive diagnosis with electron microscopy revealing characteristic 'curly' collagen fibrils in the subepithelial and anterior stromal tissues.  These degenerative changes tend to recur even after ablative procedures.

There is a great deal of clinical heterogeneity and the diagnosis is often unclear especially in younger individuals.  No doubt much of this is due to the fact that mutations in the major gene (TGFBI) responsible are also responsible for at least 5 other heritable corneal dystrophies and the argument can be made that all are variants of the same condition (vida infra).

Systemic Features: 

No systemic disease is associated with this corneal disease.

Genetics

Thiel-Behnke dystrophy is an autosomal dominant disorder.  However, it is genetically heterogeneous as mutations in at least two genes seem to produce the same phenotype. The majority of cases result from mutations in the TGFBI gene (5q31) but other corneal dystrophies (granular I or Groenouw type I, combined granular/lattice or Avellino type, Reis-Bucklers, epithelial basement membrane disease, and lattice type I) have mutations in the same gene.  This is a classic example of the variable expressivity of a single gene mutation characteristic of autosomal dominant disease. 

A second locus has been identified in a large 4 generation pedigree in which a presumed causative mutation was found on chromosome 10 (10q24). Some individuals in this family had evidence of two distinct types of dystrophies in the same cornea.  The responsible gene has not been identified. Genotyping is necessary to distinguish between the two disorders.

Pedigree: 
Autosomal dominant
Treatment
Treatment Options: 

Ablative treatments of the diseased cornea can be effective in reducing symptoms for extended periods but eventually the degenerative changes recur.  Acute erosions can be treated with hyperosmotic agents with some improvement.

References
Article Title: 

Reevaluation of corneal dystrophies of Bowman's layer and the anterior stroma (Reis-Bücklers and Thiel-Behnke types): a light and electron microscopic study of eight corneas and a review of the literature

Kuchle M, Green WR, Volcker HE, Barraquer J. Reevaluation of corneal dystrophies of Bowman's layer and the anterior stroma (Reis-Bucklers and Thiel-Behnke types): a light and electron microscopic study of eight corneas and a review of the literature. Cornea. 1995 Jul;14(4):333-54. Review.

PubMed ID: 
7671605

Pages

Subscribe to RSS - corneal opacities